Analyzing NewGenIvf Group (NASDAQ:NIVF) & Quipt Home Medical (NASDAQ:QIPT)

Quipt Home Medical (NASDAQ:QIPT) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Volatility & Risk

Quipt Home Medical has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.36, suggesting that its stock price is 136% less volatile than the S&P 500.

Institutional & Insider Ownership

42.9% of Quipt Home Medical shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 13.4% of Quipt Home Medical shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Quipt Home Medical and NewGenIvf Group, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quipt Home Medical	1	0	3	2	3.00
NewGenIvf Group	0	0	0	0	0.00

Quipt Home Medical presently has a consensus target price of $6.25, suggesting a potential upside of 146.06%. Given Quipt Home Medical’s stronger consensus rating and higher probable upside, equities analysts clearly believe Quipt Home Medical is more favorable than NewGenIvf Group.

Profitability

This table compares Quipt Home Medical and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quipt Home Medical	-2.90%	-6.70%	-2.94%
NewGenIvf Group	N/A	N/A	N/A

Earnings & Valuation

This table compares Quipt Home Medical and NewGenIvf Group”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quipt Home Medical	$245.91 million	0.45	-$6.76 million	($0.17)	-14.94
NewGenIvf Group	$5.14 million	0.21	$130,000.00	N/A	N/A

NewGenIvf Group has lower revenue, but higher earnings than Quipt Home Medical.

Summary

Quipt Home Medical beats NewGenIvf Group on 7 of the 13 factors compared between the two stocks.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

About NewGenIvf Group

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.